With six swords unleashed simultaneously, from AI computing power to innovative drugs, can this round of Hong Kong IPOs turn the tide?
The Hong Kong Stock Exchange has finally ushered in its most intensive wave of IPOs in recent times! On October 30th, six new stocks—Harmony Pharmaceutical-B (00054), Yuanxin Energy Storage (09621), Xinde Semiconductor (07672), Denglin Technology-P (09917), Xinhehua (02206), and Hongxinyu (02681)—were launched on the same day, bringing together six groups of investors! The current Hong Kong stock IPO market is no longer an era of "buying every IPO". As of October 23, the first-day failure rate of 117 IPOs this year has soared from just over 10% in the first half of the year to nearly 30%, with a cumulative failure rate of 65%!
$Weiyi Intelligent Manufacturing (03275)$ recorded a margin ratio of 32 times, but its offering was postponed due to a lack of cornerstone support. $Dongshan Precision (02384)$ introduced 20 cornerstone companies and issued at a discount, but the margin subscription by retail investors was still only 0.39 times! Therefore, in the current extremely unfavorable market environment, the quality of these six new stocks varies greatly, and we need to take a closer look at them one by one!